Laura Sutcliffe

Stock Analyst at UBS

(1.22)
# 3,594
Out of 4,914 analysts
6
Total ratings
50%
Success rate
-5.74%
Average return

Stocks Rated by Laura Sutcliffe

ResMed
Apr 24, 2025
Maintains: Buy
Price Target: $290$285
Current: $276.61
Upside: +3.03%
Telix Pharmaceuticals
Jan 27, 2025
Maintains: Buy
Price Target: $21$22
Current: $13.50
Upside: +62.96%
argenx SE
Jun 18, 2021
Initiates: Buy
Price Target: $390
Current: $594.87
Upside: -34.44%
Galapagos NV
Dec 20, 2019
Downgrades: Neutral
Price Target: n/a
Current: $32.50
Upside: -